Huron Consulting Group Inc. (NASDAQ:HURN) Director Sells $62,325.00 in Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director John Mccartney sold 500 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.65, for a total transaction of $62,325.00. Following the sale, the director now directly owns 56,688 shares in the company, valued at approximately $7,066,159.20. The trade was a 0.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Huron Consulting Group Stock Performance

NASDAQ HURN opened at $125.68 on Thursday. The company has a market capitalization of $2.23 billion, a price-to-earnings ratio of 27.32 and a beta of 0.60. Huron Consulting Group Inc. has a twelve month low of $84.26 and a twelve month high of $131.06. The stock has a fifty day simple moving average of $122.62 and a 200 day simple moving average of $111.62. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings data on Tuesday, October 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.11. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The company had revenue of $370.00 million during the quarter, compared to the consensus estimate of $377.63 million. During the same period last year, the company earned $1.39 earnings per share. The firm’s revenue was up 3.3% compared to the same quarter last year. Sell-side analysts expect that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Ashton Thomas Private Wealth LLC acquired a new position in Huron Consulting Group in the second quarter valued at $28,000. Assetmark Inc. raised its position in shares of Huron Consulting Group by 7.0% in the 3rd quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock worth $149,000 after acquiring an additional 90 shares in the last quarter. MML Investors Services LLC bought a new position in shares of Huron Consulting Group in the 3rd quarter worth about $220,000. Peapack Gladstone Financial Corp acquired a new position in shares of Huron Consulting Group in the 3rd quarter valued at about $220,000. Finally, Orion Portfolio Solutions LLC bought a new stake in shares of Huron Consulting Group during the 3rd quarter valued at about $264,000. Institutional investors and hedge funds own 93.90% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on HURN shares. Barrington Research raised their price objective on Huron Consulting Group from $137.00 to $142.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Benchmark restated a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a report on Wednesday, October 30th. Finally, StockNews.com upgraded shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, Huron Consulting Group currently has a consensus rating of “Buy” and a consensus price target of $133.00.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.